Brauer, Ruth

Diabetes medications and risk of Parkinson’s disease: a cohort study of patients with diabetes

Brauer, R., Wei, L., Ma, T., Athauda, D., Girges, C., Vijiaratnam, N., Auld, G., Whittlesea, C., Wong, I., & Foltynie, T. (2020) · Brain

Parkinson's Disease Mechanisms and TreatmentsDiabetes Treatment and Management

Cited by 233

Psychotropic medicine consumption in 65 countries and regions, 2008-19: A longitudinal study

Brauer, R., Alfageh, B., Blais, J. E., Chan, E. W., Chui, C. S. L., Hayes, J. F., Man, K. K. C., Lau, W. C. Y., Yan, V. K. C., Beykloo, M. Y., et al. (2021) · The Lancet Psychiatry

Mental Health Treatment and AccessPharmaceutical Economics and Policy

Cited by 203

Orlistat and the risk of acute liver injury: self controlled case series study in UK Clinical Practice Research Datalink

Douglas, I. J., Langham, J., Bhaskaran, K., Brauer, R., & Smeeth, L. (2013) · BMJ

Drug-Induced Hepatotoxicity and ProtectionPharmacology and Obesity Treatment

Cited by 73

Stakeholders' views on the use of psychotropic medication in older people: a systematic review

Bednarczyk, E., Cook, S., Brauer, R., & Garfield, S. (2022) · Age and Ageing

Pharmaceutical Practices and Patient OutcomesGeriatric Care and Nursing Homes

Cited by 22